Loneliness Group Intervention

Loneliness Group Intervention for Geriatric Psychiatry Inpatients

The goal of this pilot study is to determine the feasibility and acceptability of a group loneliness intervention in geriatric psychiatry inpatients. This type of group loneliness intervention is based on functional analytic psychotherapy and is called Awareness, Courage, and Love Groups.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

The objective of our clinical trial is to adapt, implement, and evaluate a type of loneliness group intervention called Awareness, Courage, and Love Groups for older adults in a psychiatric unit. The following research questions will be answered: (a) Are ACL groups with geriatric psychiatry inpatients feasible and acceptable? (b) Do such ACL groups demonstrate preliminary efficacy?

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • London, Ontario, Canada, N6C 0A7
        • Parkwood Institute Mental Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Admission to geriatric psychiatry inpatient unit

Exclusion Criteria:

  • Individuals who are disoriented to person, delirious, unable to tolerate or participate meaningfully in the group, or otherwise unable to provide consent to research and psychotherapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment
Treatment group will receive Awareness, Courage, and Love Groups for loneliness.
Groups based on the Awareness, Courage, and Love framework from functional analytic psychotherapy
Active Comparator: Control
Control group will receive treatment as usual in the form of Mutual Help Meetings.
Groups based on treatment as usual where patients gather to discuss how they can help others on the ward, and make requests for how others can help them.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inclusion of Other in the Self Scale (IOS)
Time Frame: Up to 2 months
Brief single-item pictorial measure of social closeness. The minimum value is 1, the maximum value is 7, and higher scores indicate a better outcome.
Up to 2 months
UCLA Loneliness Scale (ULS-6)
Time Frame: Up to 2 months
Brief measure of loneliness. The minimum value is 6, the maximum value is 24, and higher scores indicate a worse outcome.
Up to 2 months
Relational Health Indices (RHI)
Time Frame: Up to 2 months
Brief measure of group relational health. The minimum value is 8, the maximum value is 40, and higher scores indicate a better outcome.
Up to 2 months
Quantitative Program Satisfaction
Time Frame: Up to 2 months
Brief measure of program satisfaction. The minimum value is 0, the maximum value is 16, and higher scores indicate a better outcome.
Up to 2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cantril Self-Anchoring Striving Scale
Time Frame: Up to 2 months
1 item pictorial scale of subjective wellbeing from 0 (minimum) to 10 (maximum). A higher score indicates a better outcome.
Up to 2 months
Sacred Moment Qualities (SMQ)
Time Frame: Up to 2 months
Brief measure of perceived sacred qualities, adapted from Pargament et al. (2014). The minimum value is 11, the maximum value is 55, and higher scores indicate a better outcome.
Up to 2 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction Questionnaire
Time Frame: Up to 2 months
Brief open-ended questions about program satisfaction. Responses are qualitative.
Up to 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elisabeth VanBussel, MD, St. Joseph's Health Care London

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2024

Primary Completion (Estimated)

August 25, 2027

Study Completion (Estimated)

September 30, 2027

Study Registration Dates

First Submitted

November 9, 2022

First Submitted That Met QC Criteria

November 9, 2022

First Posted (Actual)

November 17, 2022

Study Record Updates

Last Update Posted (Estimated)

September 24, 2025

Last Update Submitted That Met QC Criteria

September 22, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 12528

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe